Lupin Philippines Inc Pharmaceutical Import Profile — Philippines (DGFT 2022–2026)

Name: Lupin Philippines Inc Pharmaceutical Import Records from India — 3 Products, $2.2M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Lupin Philippines Inc — Pharmaceutical Importer Profile (2026) | 3 Products, $2.2M Trade | TransData Nexus

Who Are the Verified Indian Suppliers to Lupin Philippines Inc?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Lupin Limited	$3.0M	81	80.7%
Ahlcon Parenterals (india) Limited	$525.1K	13	13.9%
Invex Health Private Limited	$150.0K	3	4.0%
Ahlcon Parenterals India Limited	$50.0K	1	1.3%

Lupin Philippines Inc sources from 4 verified Indian suppliers across 54 distinct formulations. The sourcing is highly concentrated — Lupin Limited accounts for 80.7% of total imports, indicating a strategic single-source relationship.

What Formulations Does Lupin Philippines Inc Import?

Formulation	Value	Ships
Duomax 24x14t alu / alu philippines rifampin and isoniazid	$500.0K	10
Salbutamol & ipratropium bromide	$400.9K	9
Quadmax 12x14t alu / alu philippines rifampin isoniazid pyrazinamide and ethambutol hydrochloride tablets	$200.0K	4
Duomax 24x14t alu / alu philippines rifampin and isoniazid	$150.0K	3
Quadmax 12x14t alu / alu philippines rifampin, isoniazid, pyrazinamide and ethambutol hydrochloride tablets	$150.0K	3
Quadmax 20x4t (philippines)rifampin 150isoniazid 75 pyrazinamide 400 and ethambutol hcl 275 MG tablets USP	$150.0K	3

What Products Does Lupin Philippines Inc Import?

Top Products by Import Value

1Ethambutol$850.0K 2Pyrazinamide$850.0K 3Ipratropium$484.3K

Lupin Philippines Inc Therapeutic Categories — 2 Specializations

Lupin Philippines Inc imports across 2 therapeutic categories, with Tuberculosis Medications (77.8%), Respiratory (22.2%), representing the largest segments. The portfolio is concentrated — top 5 products = 100% of total imports.

Tuberculosis Medications

2 products · 77.8% · $1.7M

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Ethambutol	Tuberculosis Medications	$850.0K	17	0.1%	13
2	Pyrazinamide	Tuberculosis Medications	$850.0K	17	0.1%

Key Metrics

Total Import Value$2.2M

Products3

Shipments45

Categories2

CountryPhilippines

#1 Rankings0

Indian Suppliers4

Formulations54

Top Categories

Tuberculosis Medications77.8%

Respiratory22.2%

Last updated: March 28, 2026

Lupin Philippines Inc — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Lupin Philippines Inc. is a pharmaceutical importer and distributor based in the Philippines, specializing in the registration, importation, marketing, and distribution of pharmaceutical products. Established on December 20, 2010, the company operates as a wholly-owned subsidiary of Nanomi B.V., formerly known as Lupin Holdings B.V., which is registered in the Netherlands. The ultimate parent company is Lupin Limited, an Indian multinational pharmaceutical company listed on the Bombay Stock Exchange.

Headquartered in Makati City, Lupin Philippines Inc. plays a significant role in the Philippine pharmaceutical distribution network. The company is involved in the importation and distribution of various pharmaceutical formulations, including tablets, capsules, syrups, and injections, sourced primarily from India. This strategic positioning enables Lupin Philippines Inc. to contribute to the availability of essential medications in the Philippine market, particularly in therapeutic areas such as tuberculosis and respiratory conditions.

2Distribution Network

Lupin Philippines Inc. maintains a centralized distribution model with its primary operations based in Makati City, Metro Manila. While specific details regarding additional warehouse locations and logistics capabilities are not publicly disclosed, the company's strategic location in Makati facilitates efficient distribution across the Philippines. This centralization allows for streamlined logistics and effective coverage of the Philippine archipelago, ensuring timely delivery of pharmaceutical products to various regions.

Supplier Relationship Intelligence — Lupin Philippines Inc

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Lupin Philippines Inc. exhibits a high degree of supplier concentration, with 80.7% of its total import value sourced from Lupin Limited, an Indian multinational pharmaceutical company. This significant reliance on a single supplier indicates a strategic choice to maintain a consistent and reliable supply chain. The stability of this relationship is further evidenced by the substantial number of shipments—81 in total—suggesting a well-established and dependable partnership. However, this concentration also presents a potential risk; any disruptions at Lupin Limited could impact Lupin Philippines Inc.'s ability to meet market demand. Diversifying the supplier base could mitigate such risks and enhance supply chain resilience.

2Supply Chain Resilience

Lupin Philippines Inc.'s supply chain resilience is closely tied to its primary supplier, Lupin Limited. The company's import portfolio includes a diverse range of 54 unique pharmaceutical formulations, indicating a broad product offering. However, the heavy reliance on a single supplier for the majority of imports suggests potential vulnerabilities. To enhance resilience, it would be prudent for Lupin Philippines Inc. to establish relationships with additional suppliers and ensure that all imported products comply with the Philippines' regulatory standards, including Good Manufacturing Practice (GMP) certifications.

3Strategic Implications

The current sourcing pattern of Lupin Philippines Inc. positions it as a key distributor of Lupin Limited's products within the Philippine market. This strategic alignment allows for streamlined operations and potentially favorable terms due to the volume of business conducted. For Indian exporters seeking to become alternative suppliers, understanding Lupin Philippines Inc.'s product preferences and regulatory requirements is essential. Offering products that complement Lupin Limited's offerings or fill existing gaps in Lupin Philippines Inc.'s portfolio could present viable opportunities for collaboration.

TransData Nexus Research · Verified DGFT customs dataMar 2026

Importing Pharmaceuticals into Philippines — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Philippines

1Regulatory Authority & Framework

The Food and Drug Administration (FDA) of the Philippines is the primary regulatory body overseeing the importation and distribution of pharmaceutical products. The FDA operates under the Department of Health (DOH) and is responsible for ensuring the safety, efficacy, and quality of drugs entering the country. Key legislation governing pharmaceutical imports includes the FDA Act of 2009 (Republic Act No. 9711) and the Food, Drugs, and Devices Act (Republic Act No. 3720). These laws mandate that all pharmaceutical products be registered with the FDA before they can be imported, sold, or distributed in the Philippines. (respicio.ph)

2Import Licensing & GMP

Importers of pharmaceutical products in the Philippines must secure a License to Operate (LTO) from the FDA. This license authorizes the importation and distribution of specific pharmaceutical products. Additionally, imported pharmaceutical products must be registered with the FDA, ensuring they meet the required safety, efficacy, and quality standards. Good Manufacturing Practice (GMP) certification is a critical component of this process, as it verifies that manufacturing facilities adhere to internationally recognized standards. The FDA recognizes GMP certifications from various regulatory bodies, including the European Union (EU), the World Health Organization (WHO), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). (respicio.ph)

3Quality & Labeling

Imported pharmaceutical products must undergo batch testing by the FDA to confirm their conformity with established specifications. Stability studies are also required to ensure that products maintain their quality throughout their shelf life. Labeling requirements stipulate that product labels be in English or Filipino, with specific information such as the product's generic and brand names, dosage form, strength, and the name and address of the manufacturer or distributor. Serialization mandates may apply to facilitate traceability and prevent counterfeit products from entering the market. (respicio.ph)

4Recent Regulatory Changes

In August 2024, the Department of Health of the Philippines issued Administrative Order No. 2024-0012, outlining regulations for registering pharmaceutical products and Active Pharmaceutical Ingredients (APIs) intended exclusively for export. This order sets forth guidelines, requirements, and procedures for the registration process of export-only pharmaceutical products and APIs. While this regulation primarily targets export activities, it underscores the Philippines' commitment to maintaining stringent standards for pharmaceutical products, which may indirectly affect importers like Lupin Philippines Inc.

TransData Nexus Research · Philippines regulatory databasesMar 2026

Seller's Guide — How to Become a Supplier to Lupin Philippines Inc

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Lupin Philippines Inc., particularly if they can offer products that complement Lupin Limited's offerings or fill existing gaps in Lupin Philippines Inc.'s portfolio. For instance, introducing innovative formulations or addressing unmet needs in other therapeutic areas could present viable opportunities. However, any potential supplier must ensure compliance with the Philippines' regulatory requirements, including obtaining the necessary licenses and certifications, to establish a successful partnership.

2Requirements & Qualifications

Indian exporters seeking to supply Lupin Philippines Inc. and the broader Philippine market must obtain a License to Operate (LTO) from the FDA, authorizing them to import and distribute pharmaceutical products. Additionally, products must be registered with the FDA and comply with Good Manufacturing Practice (GMP) standards recognized by the FDA. This includes certifications from bodies such as the European Union (EU), the World Health Organization (WHO), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Ensuring that products meet these standards is crucial for market entry and acceptance. (respicio.ph)

3How to Approach

To establish a relationship with Lupin Philippines Inc., potential suppliers should first ensure compliance with the Philippines' regulatory requirements, including obtaining the necessary licenses and certifications. Engaging in direct communication with Lupin Philippines Inc. to understand their specific product needs and quality standards is essential. Participating in relevant tenders and demonstrating the value proposition of their products can further facilitate collaboration. Understanding the regulatory filing strategy and expected timelines for product registration with the FDA will also aid in

TransData Nexus Research · Industry procurement practicesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Buyer Matching: Lupin Philippines Inc identified across shipments using consignee name normalization, aggregating 3 name variants.
2.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
3.Market Share: Calculated per product as Lupin Philippines Inc's capped value divided by total Indian exports for that product.
4.Shipment Count: Based on 45 individual customs records matching Lupin Philippines Inc.
5.Supplier Verification: Lupin Philippines Inc sources from 4 verified Indian suppliers across 54 formulations, confirmed from customs records.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

3 Products Tracked

2 therapeutic categories

Expert-Reviewed

By pharmaceutical trade specialists

Lupin Philippines Inc

Lupin Philippines Inc — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Lupin Philippines Inc?

What Formulations Does Lupin Philippines Inc Import?

What Products Does Lupin Philippines Inc Import?

Top Products by Import Value

Lupin Philippines Inc Therapeutic Categories — 2 Specializations

Import Portfolio — Top 3 by Import Value

Key Metrics

Top Categories

Lupin Philippines Inc — Corporate Profile & Information

1Company Overview

2Distribution Network

Indian Suppliers

Related Trade Data

Need Detailed Data?

3Industry Role

Supplier Relationship Intelligence — Lupin Philippines Inc

1Sourcing Concentration Analysis

2Supply Chain Resilience

3Strategic Implications

Importing Pharmaceuticals into Philippines — Regulatory Framework

1Regulatory Authority & Framework

2Import Licensing & GMP

3Quality & Labeling

4Recent Regulatory Changes

Lupin Philippines Inc — Procurement Pattern Analysis

1Product Strategy

2Sourcing Profile

3Market Positioning

Seller's Guide — How to Become a Supplier to Lupin Philippines Inc

1Opportunity Assessment

2Requirements & Qualifications

3How to Approach

Frequently Asked Questions — Lupin Philippines Inc

What products does Lupin Philippines Inc import from India?

Who supplies pharmaceuticals to Lupin Philippines Inc from India?

What is Lupin Philippines Inc's total pharmaceutical import value?

What therapeutic categories does Lupin Philippines Inc focus on?

Get Full Lupin Philippines Inc Import Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Data Source & Methodology